Insitro is a data-driven drug discovery and development company that is reprogramming the way drugs are created by integrating machine learning and high-throughput biology at scale. Founded in 2018 by Daphne Koller, Insitro aims to generate predictive models of human disease and develop novel therapeutics. The company focuses on building large, high-quality datasets, deriving novel biological insights through machine learning, and translating these insights into impactful medicines for patients.
Primary hub for research and development, machine learning model creation, high-throughput biological data generation, and corporate operations.
State-of-the-art laboratories equipped for high-throughput biology, automation, and 'omics data generation, alongside collaborative workspaces designed to foster innovation between computational and biological teams.
A highly collaborative, science-driven, and mission-oriented environment. Emphasis on interdisciplinary teamwork, continuous learning, innovation, and leveraging data to solve complex biological problems.
Serves as the nerve center for Insitro's pioneering approach to integrating machine learning with biology, driving all strategic and operational aspects of the company's mission to transform drug discovery.
While Insitro's primary operations, including its advanced laboratories and computational infrastructure, are centralized in its South San Francisco headquarters, its research aims to address global health challenges. The company engages in strategic collaborations with global pharmaceutical partners (e.g., Boehringer Ingelheim, previously Bristol Myers Squibb) and leverages diverse datasets, reflecting a global outlook in its mission to discover and develop new medicines. Its investor base is also international, further underscoring its global connections and aspirations.
279 E Grand Ave
South San Francisco
CA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, insitro' leadership includes:
insitro has been backed by several prominent investors over the years, including:
Insitro has strengthened its executive leadership over the past year with key appointments in finance and business development, positioning the company for continued strategic growth and advancement of its pipeline.
Discover the tools insitro uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Insitro commonly uses the email format combining the first initial of the first name with the full last name. This is a standard convention in many technology and biotechnology companies.
[first_initial][last]@insitro.com
Format
dkoller@insitro.com
Example
90%
Success rate
Insitro Press Release • 2024-05-21
Insitro and Boehringer Ingelheim entered a five-year collaboration to discover and develop new medicines for metabolic diseases, leveraging Insitro's human-centric platform. Insitro will receive an upfront payment and is eligible for milestone payments and royalties....more
Insitro Press Release • 2024-02-27
Insitro announced the appointment of Sara Nayeem, M.D., M.B.A., as chief business officer (CBO). Dr. Nayeem brings extensive experience in healthcare investment, strategy, and business development to Insitro....more
Insitro Press Release • 2023-11-01
Insitro announced the appointment of Percy Sivam as chief financial officer (CFO). Mr. Sivam has a strong background in financial leadership within the biopharmaceutical industry....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including insitro, are just a search away.